Our Partners

Geistlich is the global leader in dental regeneration, backed by more than 170 years of expertise in processing and refining bone and tissue. We are dedicated to developing evidence-based products that promote the regeneration of bone, cartilage, and soft tissue — ensuring better healing, long-term stability, and improved quality of life for patients. 
With thousands of scientific studies and the highest Swiss quality standards, we have been shaping the field of regenerative medicine for decades. Through our global educational programs, reaching over 100,000 professionals each year, and our close partnerships with leading scientists, clinicians, and over 100 universities worldwide, we ensure that patients benefit from the latest scientific knowledge and advanced treatment methods. 
As a fifth-generation family-owned company, Geistlich stands for reliability, trust, and innovation. We develop our products carefully with dentists, surgeons, and patients in mind — constantly expanding our portfolio through in-house innovations and strategic partnerships. From the heart of Switzerland to the world, we deliver long-term solutions that enable the best possible patient care.  

At Nobel Biocare, we are transforming patient care beyond products, through true science, original solutions, and real innovations. We believe that every revitalized smile must not only be esthetic but also support long-term tissue health. From the macroscopic design of our implants and prosthetics to our regenerative materials and the digital solutions that bring treatment plans to life, patient wellbeing is always at the heart of what we do. We are proud to be built on the unique legacy of Professor Per-Ingvar Brånemark, whose pioneering work laid the foundation for modern implantology. This heritage continues to inspire our thriving culture of innovation, driving us to change patients’ lives through science-based excellence. 

Straumann® – the world’s leading brand for confidence in implantology and beyond. Straumann® stands for premium Swiss quality, precision and innovation delivering confidence in dentistry, backed by the largest global scientific network. As the global leader in implantology, we deliver cutting-edge innovations that are regarded as industry benchmarks and disruptive technological breakthroughs, supported by long-term scientific evidence. We push the boundaries to enable the next generation of dental care. Straumann is part of the Straumann Group, headquartered in Basel, Switzerland. The group currently employs around 12’000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.  

BioHorizons Camlog Group is a leading supplier of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions. BioHorizons Camlog is committed to developing evidence-based and scientifically proven products as well as offering continuous education according to highest standards. Headquartered in the U.S. and Europe, BioHorizons Camlog’s geographic positions enable it to efficiently serve direct subsidiaries in the Americas and Western Europe as well as its entire distribution network in more than 90 countries around the world. BioHorizons Camlog is part of Henry Schein, Inc.

Since 1888, Hager & Meisinger GmbH has stood for precision and innovation in dentistry. At our facility in Neuss, Germany, we manufacture highly specialized medical products that embody our “Made in Germany” commitment to quality and reliability. With subsidiaries in Italy, France, the USA, and Asia, and over 100 international distributors, MEISINGER is a global leader in medical technology. Our rotary instruments form a core part of our portfolio, complemented by pioneering solutions in bone augmentation, implantology, digital dentistry, and aligner therapy – all designed to support outstanding dental care worldwide.

Patent™ represents the latest generation in tooth replacement. While conventional dental implants achieve only osseointegration, Patent™ Dental Implants also form a soft-tissue bond—achieving complete biological integration. This has been scientifically demonstrated as the key breakthrough in preventing peri-implant disease. Using a multi-patented process, the transmucosal Patent™ surface is given mucophilic properties and a topography modelled after the natural tooth. As a result, epithelial cells grow onto the surface shortly after insertion, forming a defense barrier that protects the tissue against bacterial invasion. This is how inflammation and recession are minimized, the progression from mucositis to peri-implantitis is prevented, and long-term stable esthetics are ensured.
 

TRI® is a fast-growing global provider of inspiring digital implant solutions from Switzerland. Driven by innovation, simplicity, and performance, TRI® delivers high-quality and easy-to-use implant systems for the benefit of patients worldwide. With its pioneering matrix® technology—the world’s first dental implant designed for abutment-free, fully digital restorations—TRI® is leading the digital transformation in implantology and empowering dental professionals to unlock a new level of efficiency and precision.
 

Headquartered in Bürmoos, Austria, the international W&H Group is a global leader in the development and manufacture of medical technology products. Passion and innovation are the motor of the company. High-quality product and service solutions, a modern corporate structure, a strong focus on research and development as well as social responsibility make W&H a locally and globally successful family business. About 1,300 employees contribute to the production of hardware and software products for use in the dental, medical and veterinary industries.